Characterization of Dextran Sulfate-Induced Guinea Pig Tracheal Plasma Extravasation.

DOI Web Site Web Site Web Site PubMed 参考文献23件

書誌事項

タイトル別名
  • Characterization of Dextran Sulfate-Ind

この論文をさがす

抄録

We examined the effect of dextran sulfate on guinea pig tracheal vascular permeability. I. v. injection of dextran sulfate (10-100 mg/kg) with captopril (1 mg/kg) induced guinea pig tracheal plasma extravasation. The i. v. administration of bradykinin (0.8-8 μg/kg) with captopril (1 mg/kg) also induced plasma extravasation. Bradykinin B2 antagonists, D-Arg[Hyp3-Thi5-D-Tic7-Tic8]-bradykinin (NPC 16731) and D-Arg[Hyp3-Thi5-D-Tic7-0ic8]-bradykinin (Hoe 140), reduced both dextran sulfate (32 mg/kg)- and bradykinin (2.5 μg/kg)-induced tracheal plasma extravasation in a dose-dependent manner. However, a cyclooxygenase inhibitor, indomethacin (1 mg/kg), and a neurokinin antagonist, {N-[N2-[N-[N-[N-[2, 3-didehydro-N-methyl-N-[N-[3-(2-pentylphenyl)-propionyl]-L-threonyl] tyrosyl-L-Ieucynyl]-D-phenylalanyl]-L-allo-threonyl]-L-asparaginyl]-L-serine-ϒ-lactone} (FK 224) (1 mg/kg), had no effect on tracheal plasma extravasation induced by dextran sulfate and bradykinin. Dextran sulfate (32 mg/kg) with captopril (1 mg/kg) greatly increased the bradykinin level in guinea pig plasma. This evidence suggests that dextran sulfate releases bradykinin in guinea pig plasma and causes guinea pig tracheal plasma extravasation via the activation of bradykinin B2-receptors.

収録刊行物

  • Jpn.J.Pharmacol.

    Jpn.J.Pharmacol. 72 (3), 217-221, 1996

    公益社団法人 日本薬理学会

参考文献 (23)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ